Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-04-000042
Filing Date
2004-05-10
Accepted
2004-05-10 13:20:30
Documents
2
Period of Report
2004-05-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2868
2 confirmstmt_niblack.htm EX-24 1427
  Complete submission text file 0000875320-04-000042.txt   6052
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O PFIZER INC 235 EAST 42ND ST ATTN: CORPORATE SEC NEW YORK NY 10017 2127334802
NIBLACK JOHN F (Reporting) CIK: 0001174456 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 04792024